BioSpace53 分钟
Alnylam’s Amvuttra Approved as First RNAi Silencer for Rare Type of Cardiomyopathy
The FDA approval of Alnylam’s Amvuttra sets up a three-way race with Pfizer and BridgeBio, which both market transthyretin ...
News-Gazette29 分钟
UI Trustees | Killeen: Federal funding model has 'driven innovation'
While we may have a panic button, we’re going to move it aside,” Killeen told the UI Board of Trustees on Thursday, hours ...